Study: vaccine induced inflammation cause of obesity epidemic - not diet

Comments by Health Impact News Editor

Childhood obesity is now a reason why the state could take away children from their parents. The rationale is that if a child is obese, it is the parents fault, because they failed to feed them properly. It is assumed that all childhood obesity is a result of diet.

However, most of us have probably seen first-hand just how different children are when it comes to food and putting on weight. Some children can eat junk food most of the time and never add weight, while some children can eat a healthy, organic diet and still add pounds.

Dr. J. Bart Classen has published a study claiming that the evidence for the overwhelming problem of childhood obesity is not diet, but “vaccine induced inflammation.”

Press Release

A newly published paper in June’s Journal of Endocrinology, Diabetes & Obesity, 5(3): 1107, by immunologist J. Bart Classen, MD of Classen Immunotherapies provides further proof of the dangers of vaccines.

The paper reviews the growing evidence that many cases of obesity, type 2 diabetes and metabolic syndrome are inflammatory conditions and that vaccine induced inflammation is the cause of the epidemic of these diseases.

Upon receiving a vaccine some individuals’ immune system becomes hyper active leading to autoimmune destruction of insulin secreting cells and the development of type 1 diabetes. Many other individuals produce increased cortisol and other immune suppressing molecules, to suppress the vaccine induced inflammation.

This increased production leads to type 2 diabetes, obesity and metabolic syndrome. The new paper reviews evidence supporting vaccines, not diet, as a cause of the epidemics of obesity, type 2 diabetes and metabolic syndrome.

Dr. J. Bart Classen states:

“The new paper reviews proof that vaccines are much more dangerous than the public is lead to believe. Adequate testing has never been performed to indicate that there is an overall improvement in health from immunization. One major problem with vaccines is the one dose fits all approach. In order to induce protection to infection in the 1% of the population with the weakest immune system, vaccines are over stimulating the immune system of the remaining 99% of the population and this is leading to epidemics of inflammatory diseases.”

Abstract

There is an epidemic of obesity, type 2 diabetes, metabolic syndrome and associated conditions. Patients with these conditions often have markers of increased inflammation. Many researchers have published that nutrition overload caused the epidemic of obesity and the associated inflammation which leads to type 2 diabetes and metabolic syndrome. A contrasting view has provided extensive evidence that vaccine induced immune overload has caused an epidemic of inflammation and this inflammation caused epidemics of obesity, type 2 diabetes and metabolic syndrome. The data reviewed in these manuscripts provides proof that immune overload, not nutrition overload has been the major contributing factor for the epidemics and inflammation associated with the epidemics. Several lines of evidence are reviewed including evidence that inflammation precedes obesity in many patients, the lack of inflammation in many obese patients, an epidemic of inflammation in thin patients, and an epidemic of obesity in children under 6 months of age. The failure to control the obesity epidemic is blamed on the focus on nutrition and ignoring the root cause, vaccine induced immune overload. Once a patient has developed metabolic syndrome with type 2 diabetes providers are too frequently subjecting their patients to further immune overload by administering yearly influenza vaccines and many other vaccines. This action makes metabolic syndrome more difficult to reverse. The plan to reduce obesity must be focused on preventing immune overload and not blaming patients for their diet. The epidemic of obesity can be reversed through discontinuation of vaccine practices that result in immune overload.

Read the full study.

REGISTER NOW

By Dr JB Classen / President and Chief Executive Officer of Classen Immunotherapies

John Barthelow Classen, M. D., M. B. A., is President and Chief Executive Officer of Classen Immunotherapies. Besides overseeing development of the company’s products, he has acted as a biotechnology consultant advising several New York investment firms. He advised the biotechnology analyst and several investment bankers at Prudential Securities between 1991 and 1994 .

Dr. Classen was employed at the National Institutes of Health in the Laboratory of Immunology, NIAID, between 1988 and 1991 before leaving to found Classen Immunotherapies in 1991. He received his M.D. from the University of Maryland in 1988 and his M.B.A. from Columbia University in 1992.

Dr. Classen holds a number of patents, specifically regarding “the act of reading the published scientific literature and using it to create vaccination schedules that minimize immune disorders,” and has sued four biotechnology companies over allegedly infringing on them. While a district court had found that Classen’s idea was too abstract to be patented, he appealed the case and the appeals court found otherwise.

(Source: vaccineimpact.com; August 11, 2017; http://tinyurl.com/ybe4epwr)
Back to INF

Loading please wait...